Search results for "Combination"

showing 10 items of 1379 documents

Lineage diversification and recombination in type-4 human astroviruses.

2013

Abstract Human astroviruses (HAstVs) are important enteric pathogens and can be classified genetically and antigenically into eight types. During surveillance of HAstVs in Italy, type-4 HAstVs were detected only sporadically and found to cluster into two distinct genetic groups. Upon sequence analysis of the 3′ end of the polymerase gene (ORF1b) and of the full-length ORF2, the 2008 type-4 HAstV strains were characterised as a novel ORF2 genetic lineage, designated as 4c. The 2008 type-4 HAstVs also shared the ORF1b gene with similar HAstV-4c strains detected globally, thus displaying a conserved ORF1b/ORF2 asset. By interrogation of the databases, this novel lineage 4c accounted for 60.8% …

Microbiology (medical)Settore MED/07 - Microbiologia E Microbiologia ClinicaLineage (genetic)Sequence analysisMolecular Sequence DataSequence alignmentBiologyMicrobiologyAstrovirusFecesOpen Reading FramesAstrovirus Epidemiology Genotyping Italy Viral gastroenteritisPhylogeneticsAstroviridae InfectionsGenetic variationGeneticsHumansAmino Acid SequenceMolecular BiologyGenotypingGeneEcology Evolution Behavior and SystematicsPhylogenyGeneticsRecombination GeneticBase SequenceSequence Homology Amino AcidSequence Analysis RNAvirus diseasesGenetic Variationbiology.organism_classificationRNA-Dependent RNA PolymeraseGastroenteritisInfectious DiseasesRNA ViralCapsid ProteinsSequence AlignmentMamastrovirusInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
researchProduct

Evidence for recombination between the pandemic GII.4 norovirus strains New Orleans 2009 and Sydney 2012

2013

ABSTRACT During 2012, a novel pandemic GII.4 norovirus variant, Sydney 2012, emerged worldwide. A signature of the variant was a GII.Pe ORF1, in association with GII.4 Apeldoorn 2008-like ORF2-ORF3 genes. We report the detection of recombinant GII.4 Sydney 2012 strains, possessing the ORF1 gene of the former pandemic variant New Orleans 2009.

Microbiology (medical)Settore MED/07 - Microbiologia E Microbiologia ClinicaNorovirus GII.4 Sydney 2012 New Orleans 2009 recombinationvirusesMolecular Sequence DataBiologymedicine.disease_causeOpen Reading Framesfluids and secretionsViral geneticsVirologyPandemicmedicineHumansChildPandemicsCaliciviridae InfectionsRecombination GeneticGeneticsNorovirusvirus diseasesSequence Analysis DNAVirologyChild PreschoolNorovirusRNA Viral
researchProduct

Recombinant norovirus GII.g/GII.12 gastroenteritis in children.

2011

Recombinant GII.g/GII.12 norovirus (NoV) strains emerged in 2008 in Australia and subsequently have been associated with gastroenteritis outbreaks worldwide. In the winter season 2009-2010 GII.12 strains caused 16% of the NoV outbreaks in the United States. During 2009-2010 we also identified GII.g/GII.12 strains during surveillance of sporadic cases of gastroenteritis in Italian children. Severity scores were calculated for the GII.g/GII.12 NoV infections using the Vesikari scale and in two out of three paediatric cases they exceeded the median value calculated for concomitant GII.4 infections. Upon sequence analysis, the Italian strains were found to be recombinant viruses and displayed d…

Microbiology (medical)Settore MED/07 - Microbiologia E Microbiologia Clinicacongenital hereditary and neonatal diseases and abnormalitiesGenotypeSequence analysisvirusesBiologyNorovirus GII.g GII.12 Gastroenteritis Italy Recombinationmedicine.disease_causeMicrobiologylaw.inventionMicrobiologyDisease Outbreaksfluids and secretionsViral geneticslawGenotypeGeneticsmedicineHumansChildMolecular BiologyEcology Evolution Behavior and SystematicsPhylogenyNorovirus GIIRecombination GeneticPolymorphism GeneticNorovirusvirus diseasesOutbreakInfantSequence Analysis DNAVirologyGastroenteritisPhylogeographyInfectious DiseasesItalyChild PreschoolNorovirusRecombinant DNARNA ViralCapsid ProteinsWinter seasonInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
researchProduct

Genetic heterogeneity and recombination in human type 2 astroviruses

2012

ABSTRACT Novel lineages of human astrovirus (HAstV) types 2, 2c, and 2d have been identified. Upon sequencing of the 3′ end of the genome, the type 2c and 2d HAstVs were found to be open reading frame 1b (ORF1b)-ORF2 recombinant, with ORF1b being derived from type 3 and type 1 HAstVs, respectively. An ORF2 interlineage recombinant strain, 2c/2b, was also identified.

Microbiology (medical)Settore MED/07 - Microbiologia E Microbiologia Clinicafood.ingredientMolecular Sequence DataBiologyGenomelaw.inventionGenetic HeterogeneityOpen Reading FramesfoodPhylogeneticslawVirologyCluster AnalysisHumansPhylogenyRecombination GeneticGeneticsGenetic heterogeneityStrain (biology)MamastrovirusSequence Analysis DNAOpen reading frameRecombinant DNARNA Viralastrovirus genotyping ItalyRecombinationMamastrovirus
researchProduct

Optimum combination therapy regimens for HIV/HCV infection

2016

HIV-HCV co-infection mostly affects intravenous drug users, in whom prevalence has tended to decrease in recent years, while it has increased in men who have sex with men, with occurrence of acute hepatitis C. Hepatitis C has a poorer prognosis in patients co-infected with HIV, as clinical progression is faster and degree of hepatic fibrosis is greater. However, optimized ARV treatment is clearly associated with slower progression to hepatic complications. Interactions between HCV and HIV drugs are numerous, which underlines the importance of pharmacological advice for HIV-treated patients before they start HCV treatment. In HIV-HCV co-infection, treatment of hepatitis C has to be offered a…

Microbiology (medical)medicine.medical_specialtyCombination therapyHIV InfectionsHepatic ComplicationAntiviral AgentsMicrobiologyMen who have sex with men03 medical and health sciences0302 clinical medicineVirologyInternal medicineGenotypemedicineHumansDrug Interactions030212 general & internal medicineStage (cooking)Coinfectionbusiness.industryvirus diseasesHepatitis Cmedicine.diseaseHepatitis CInfectious DiseasesImmunologyCoinfectionDrug Therapy Combination030211 gastroenterology & hepatologyHepatic fibrosisbusinessExpert Review of Anti-infective Therapy
researchProduct

Consensus document on controversial issues for the treatment of hospital-associated pneumonia

2010

Background: Hospital-associated pneumonia (HAP) remains an important cause of morbidity and mortality despite advances in antimicrobial therapy. Many aspects of the treatment of HAP caused by multi-resistant Gram-positive microorganisms have been extensively studied, but controversial issues remain. Controversial issues: The aim of this GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) working group – a panel of multidisciplinary experts – was to define recommendations for some controversial issues using an evidence-based and analytical approach. The controversial issues were: (1) Is combination antibiotic therapy or monotherapy more effective in the treatment of HAP? (2) What role do…

Microbiology (medical)medicine.medical_specialtyMEDLINECochrane LibraryGram-Positive BacteriaNosocomial pneumonia Health care-associated pneumonia 16Methicillin-resistant staphylococcilaw.inventionHealth care-associated pneumoniaRandomized controlled triallawSettore MED/41 - ANESTESIOLOGIAPneumonia BacterialHumansMedicineNOSOCOMIAL PNEUMONIAMethicillin-resistant staphylococciIntensive care medicineGram-Positive Bacterial InfectionsRandomized Controlled Trials as TopicCross InfectionEvidence-Based Medicinebusiness.industryBacterial pneumoniaRetrospective cohort studyGeneral MedicineEvidence-based medicinemedicine.diseaseAnti-Bacterial AgentsQuality of evidencePneumoniaTreatment OutcomeInfectious DiseasesDrug Therapy CombinationbusinessInternational Journal of Infectious Diseases
researchProduct

Traditional endodontic surgery versus modern technique: a 5-year controlled clinical trial.

2014

In this study, we compared outcomes of traditional apicoectomy versus modern apicoectomy, by means of a controlled clinical trial with a 5-year follow-up. The study investigated 938 teeth in 843 patients. On the basis of the procedure performed, the teeth were grouped in 3 groups. Differences between the groups were the method of osteotomy (type of instruments used), type of preparation of retrograde cavity (different apicoectomy angles and instruments used for root-end preparation), and root-end filling material used (gray mineral trioxide aggregate or silver amalgam). Outcome (tooth healing) was estimated after 1 and 5 years, postoperatively. Clinical success rates after 1 year were 67% (…

Mineral trioxide aggregateAdultMalemedicine.medical_specialtyMicrosurgeryEndodontic surgery MTA amalgam prognosis statisticsmedicine.medical_treatmentDentistryOsteotomyDental AmalgamSettore MED/29 - Chirurgia MaxillofaccialeProbability of successYoung Adultstomatognathic systemSettore MED/28 - Malattie OdontostomatologicheMedicineHumansAluminum Compoundsbusiness.industrySilicatesApicoectomyOxidesGeneral MedicineOdds ratioCalcium CompoundsMiddle AgedConfidence intervalSurgeryOsteotomyClinical trialstomatognathic diseasesEndodontic surgeryDrug CombinationsOtorhinolaryngologyApicoectomyRetrograde ObturationSurgeryFemalebusinessFollow-Up StudiesThe Journal of craniofacial surgery
researchProduct

Osseous reaction to implantation of two endodontic cements : mineral trioxide aggregate (MTA) and calcium enriched mixture (CEM)

2012

Aim: The aim of the present in vivo study was to determine bone tissue reaction to calcium enriched mixture (CEM) and mineral trioxide aggregate (MTA) using a rat femur model. Study Design: Sixty-three rats were selected and randomly divided into three groups of 21 each [experimental groups (n=15), control (n=6)]. Implantation cavities were prepared in each femoral bone and randomly filled with the biomaterials only in the experimental groups. The animals in three groups were sacrificed 1, 4, and 8 weeks postoperatively. Histologic evaluations comprising inflammation severity and new bone formation were blindly made on H&E-stained decalcified 6-µm sections. Results: At 1, 4, and 8 weeks aft…

Mineral trioxide aggregateBiocompatibilityDental CementsDentistrychemistry.chemical_elementCalciumBone tissueBone and BonesEndodonticsRoot Canal Filling MaterialsDental cementIn vivomedicineAnimalsFemurRats WistarAluminum CompoundsGeneral DentistryChemistrybusiness.industrySilicatesBiomaterialOxidesCalcium Compounds:CIENCIAS MÉDICAS [UNESCO]RatsDrug Combinationsmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASResearch-ArticleCalciumSurgerybusiness
researchProduct

Response of periodontium to mineral trioxide aggregate and Biodentine: a pilot histological study on humans.

2018

Background The aim of this study was to investigate for the first time the histological response of human periodontium to mineral trioxide aggregate (MTA) and Biodentine. Methods Six patients scheduled for implant full-arch rehabilitation were randomly assigned to one of the two test groups: MTA or Biodentine treatment. For each patient, two teeth scheduled for strategic extraction were randomly assigned either to the test or to the control treatment. A lateral perforation was drilled on the root and either repaired with MTA/Biodentine or filled with gutta-percha(control). Three months later, the teeth were extracted along with the coronal third of the alveolar bone and a portion of gingiva…

Mineral trioxide aggregateMalePeriodontiumPeriodontal Ligament0206 medical engineeringPerforation (oil well)GingivaDentistryBiocompatible MaterialsPilot Projects02 engineering and technology03 medical and health sciences0302 clinical medicineMedicinePeriodontal fiberHumansSingle-Blind MethodCementumAluminum CompoundsGeneral DentistryDental alveolusAgedPain Postoperativebusiness.industrySilicatesHistologyOxides030206 dentistryPeriodontiumCalcium CompoundsMiddle Aged020601 biomedical engineeringDrug Combinationsmedicine.anatomical_structureCase-Control StudiesDentinFemaleImplantGutta-PerchabusinessToothAustralian dental journal
researchProduct

Effect of pH on compressive strength of some modification of mineral trioxide aggregate

2013

Objectives: Recently, it was shown that NanoMTA improved the setting time and promoted a better hydration process which prevents washout and the dislodgment of this novel biomaterial in comparison with WTMA. This study analyzed the compressive strength of ProRoot WMTA (Dentsply), a NanoWMTA (Kamal Asgar Research Center), and Bioaggregate (Innovative Bioceramix) after its exposure to a range of environmental pH conditions during hydration. Study Design: After mixing the cements under aseptic condition and based on the manufacturers' recommendations, the cements were condensed with moderate force using plugger into 9 × 6 mm split molds. Each type of cement was then randomly divided into three…

Mineral trioxide aggregateMaterials sciencePost hocCompressive StrengthDental CementsOdontologíaCalcium Hydroxidechemistry.chemical_compoundDental cementBiomaterials and Bioengineering in DentistryMaterials TestingPolymethyl MethacrylateComposite materialAluminum CompoundsGeneral DentistryCementCalcium hydroxideSilicatesWashoutBiomaterialOxidesCalcium CompoundsHydrogen-Ion Concentration:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludDrug CombinationsCompressive strengthOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASSurgeryResearch-ArticleHydroxyapatitesMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct